Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors
- Alia D Zander
- , Rossin Erbe
- , Yan Liu
- , Ailin Jin
- , Seung Won Hyun
- , Sayantoni Mukhopadhyay
- , Ben Terdich
- , Mario G Rosasco
- , Nirali Patel
- , Brett M Mahon
- , A Kate Sasser
- , Michelle A Ting-Lin
- , Halla Nimeiri
- , Justin Guinney
- , Douglas Adkins
- , Matthew Zibelman
- , Kyle A Beauchamp
- , Chithra Sangli
- , Michelle M Stein
- , Timothy Taxter
- Tempus AI Inc.
- Washington Univ
- Center for Immunotherapy and Precision Immuno-oncology
- Moores UCSD Cancer Center, La Jolla, United States
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations